Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/385)
- Cortez, BN, Kuo, MJM, Jha, A, Patel, M, Carrasquillo, JA, Prodanov, T et al.. Case Series: ATRX Variants in Four Patients with Metastatic Pheochromocytoma. Front Endocrinol (Lausanne). 2024;15 :1399847. doi: 10.3389/fendo.2024.1399847. PubMed PMID:39351526 PubMed Central PMC11439680.
- Nail, V, Chapot, A, Nachar, O, Gabriel, S, Moyon, A, Taieb, D et al.. Medication reconciliation enhances the accuracy of gastric emptying scintigraphy. EJNMMI Radiopharm Chem. 2024;9 (1):68. doi: 10.1186/s41181-024-00299-3. PubMed PMID:39325280 PubMed Central PMC11427626.
- Taïeb, D, Deandreis, D, Hicks, RJ. Reimagining Biologically Adapted Somatostatin Receptor-Targeted Radionuclide Therapy: Perspectives Based on Personal Experience and Observations on Recent Trials. J Nucl Med. 2024; :. doi: 10.2967/jnumed.124.268136. PubMed PMID:39299784 .
- Horowitz, T, Grimaldi, S, Dufour, H, Graillon, T, Azulay, JP, Guedj, E et al.. 18F-FDG brain PET: a metabolic predictive factor for gait improvement after cerebrospinal fluid shunting in normal pressure hydrocephalus?. Q J Nucl Med Mol Imaging. 2024; :. doi: 10.23736/S1824-4785.24.03582-9. PubMed PMID:39295448 .
- Guedj, E, Horowitz, T, Dissaux, B, Ben Salem, D. PET-MRI neuroimaging of neurovascular uncoupling related to BBB dysfunction: beyond mild traumatic injury. J Neuroradiol. 2024;51 (5):101219. doi: 10.1016/j.neurad.2024.101219. PubMed PMID:39214640 .